Keywords: lasting, benefits, cel-sci, ra, vaccine, demonstrated, corp

Lasting benefits of CEL-SCI's RA vaccine demonstrated

Article | 24 November 2008

Print This

CEL-SCI Corp of the USA announced new rheumatoid arthritis data at the 6th annual GTCbio Vaccine Conference in Vienna, Virginia, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in